Taizhou strengthens position as leading hub for food for special medical purposes

Taizhou, Jiangsu emerges as a hub for food for special medical purposes. [Photo/ourjiangsu.com]

Under the "Healthy China" strategy, Taizhou, Jiangsu is emerging as a leading center for the medical and functional food industry. A robust industrial chain integrating biotechnology, intelligent manufacturing, and quality control is rapidly taking shape. 

At Taizhou Medical High-Tech Zone, Kwins Health Pharmaceutical Jiangsu is accelerating the production of 10 approved foods for special medical purposes (FSMPs). Lin Lin, the company's marketing director, explained, "Our products are formulated based on the Chinese dietary guidelines, incorporating essential nutrients." 

"Currently, 50 percent of our raw materials are sourced domestically, and we plan to incorporate more local suppliers from Taizhou into our production network," Lin added.

Several kinds of FSMPs are on display. [Photo/ourjiangsu.com]

With broad applications and comprehensive nutritional components, FSMPs are thriving in Taizhou. In Taixing, Dongsheng Biotech, the world's largest TG enzyme production facility, operates at an annual capacity of 2,000 metric tons. As a key ingredient in FSMP formulations, TG enzyme is widely used in meat, soy, dairy, and seafood products. It helps improve food structure and enables food giants like Shuanghui to enhance their healthy food offerings.

The high-quality development of the FSMP industry also relies on robust testing and inspection capabilities. The Taizhou Food Inspection Institute is Jiangsu's only FSMP testing center. The institute is currently developing a comprehensive public service platform that integrates inspection, research, training, and standards development, ensuring quality control across the supply chain.

An FSMP production line. [Photo/ourjiangsu.com] 

Strong policy support has also fueled FSMP industry growth. In recent years, Taizhou has designated biopharmaceuticals, including FSMP, as a key strategic emerging industry, offering incentives such as up to 3 million yuan ($412,016) in funding for approved products. 

As of January 2025, the city has approved 18 FSMPs, with five leading companies and over 30 products in the pipeline, covering clinical and daily nutritional needs for all age groups. 

Ding Xiaochun, director of the FSMP supervision department at the Taizhou Market Regulation Administration, noted that the city will promote the integration of FSMP into hospitals, pharmacies, and elderly care institutions, while also working to raise public awareness and support for the industry.